Legacy Medical Consultants

In the largest ever analysis of real-world evidence, researchers at University of Southern California and Stage Analytics™, in partnership with Legacy Medical Consultants, found that tissue-based wound coverings are associated with a 28% reduction in risk of major amputation and a 20% decrease in 30-day mortality, compared to standard of care for lower-extremity diabetic ulcers. To learn more about this groundbreaking study visit: https://lnkd.in/eAxiYZ4i #healthcare #QualityAllografts #WoundCare #Diabetes #SkinSubstitutes #CMS

In April, seven Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) that if implemented will restrict access to products that could put thousands of lives at risk, including a disproportionate number of patients within marginalized communities.    We’re working with the wound care community to ensure that patients continue to have access to the treatments they need.   Learn more: https://lnkd.in/gVxHaeDV   #healthcare #QualityAllografts #WoundCare #Diabetes #Medicare #SkinSubstitutes #CMS #medicaldevices #ChronicWound 

The wound care community is coming together to fight for patient access to effective products that reduce the risk of hospitalization and amputations. More here: https://lnkd.in/gu_hh8qy

Legacy Medical Consultants is thrilled to announce that we’re expanding our headquarters. Our office space will more than double in size to accommodate our growing operations and portfolio of allografts for wound care.    Since 2020, we've experienced over 500% annualized growth in unit sales, a testament to the quality of our allografts, and commitment to patient needs.      “Our focus is on the well-being of patients who use our products,” said Legacy Chief Executive Officer Jonathan Knutz. “Our goal is to make sure doctors have the highest quality allografts available to support their patients and improve the quality of their lives. Our expansion shows our commitment to serving our customers.”       Stay tuned for updates on our exciting journey!   #LegacyExpansion #QualityAllografts #WoundCare  

Legacy Medical Consultants is excited to announce our latest product: Reeva FT™. Recently awarded Q code approval, Reeva FT™ is a terminally sterilized, dual-layered amnion/chorion allograft specifically processed to provide covering and protection during advanced wound treatment.    “There is a critical need in the wound care space for these advanced allograft products,” says Jonathan Knutz, CEO of Legacy Medical Consultants, “and we continue to deliver solutions that innovate while advancing a well-established and proven medical technology.”  To learn more, visit our website: https://lnkd.in/ej7vyRmX.

Effective wound care for diabetic patients requires a collaborative approach. Legacy Medical Consultants is dedicated to addressing the unmet clinical needs of wound patients. #diabetes

We’re excited to attend this year’s Symposium on Advanced Wound Care in Orlando May 14 -18. These pictures are a reminder of last year's fantastic event. Our CEO, Jonathan Knutz, will be delivering remarks next month.